Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Bailey Varney

Physician Assistant Johns Creek, GA Physician Assistant

NPI 1912462755 CMS profile 11285829

11315 Johns Creek Pkwy Ste 340, Johns Creek, GA 30097

Open in the dashboard

General payments

$5,775

327 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bailey Varney of Johns Creek, GA is reported in the CMS Open Payments database as having received $5,775 across 327 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,193 69
2024 General $1,793 102
2023 General $1,191 67
2022 General $1,303 73
2021 General $295 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bailey Varney
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Bailey Varney were reported at $1,193. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Bailey Varney Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $295 $132 $37–$438 $132
2022 $1,303 $155 $48–$522 $149
2023 $1,191 $167 $52–$557 $160
2024 $1,793 $178 $55–$600 $164
2025 $1,193 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,076 75 payments
  2. Novo Nordisk Inc $816 56 payments
  3. Lilly USA, LLC $724 38 payments
  4. Pfizer Inc. $581 27 payments
  5. AstraZeneca Pharmaceuticals LP $483 28 payments
  6. GlaxoSmithKline, LLC. $364 15 payments
  7. Inspire Medical Systems, Inc. $325 14 payments
  8. Biohaven Pharmaceutical Holding Company Ltd. $230 12 payments
  9. Amgen Inc. $197 5 payments
  10. Hikma Pharmaceuticals USA $103 7 payments
  11. Other $874 50 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,775 327 payments
Products named General payments · program years 2021–2025
  1. UBRELVY $672 39 payments
  2. Ozempic $544 38 payments
  3. RYBELSUS $492 35 payments
  4. NURTEC ODT $492 22 payments
  5. TRELEGY ELLIPTA $342 14 payments
  6. INSPIRE $325 14 payments
  7. MOUNJARO $309 13 payments
  8. JARDIANCE $293 19 payments
  9. QULIPTA $288 14 payments
  10. AIRSUPRA $285 17 payments
  11. Other $3,737 219 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 44 drugs

Part D claims

1,038

Median for Physician Assistant: 241

Drug cost

$71,782

Median for Physician Assistant: $4,110

Branded share of claims

25.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mounjaro Tirzepatide Brand 17 $20,098
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 18 $19,320
Eliquis Apixaban Brand 17 $13,376
Movantik Naloxegol Oxalate Brand 26 $5,507
Levothyroxine Sodium Generic 76 $1,403
Synthroid Levothyroxine Sodium Brand 11 $1,171
Valacyclovir Valacyclovir Hcl Brand 33 $1,006
Liothyronine Sodium Generic 34 $992
Duloxetine Hcl Generic 13 $860
Rosuvastatin Calcium Generic 67 $540

The 10 drugs with the highest cost, of 44 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 26 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Repatha
  • Amgen Inc. $139
$139 — —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $136
$136 — —
TRELEGY ELLIPTA
  • GlaxoSmithKline, LLC. $127
$127 18 —
UBRELVY
  • AbbVie, Inc. $122
$122 — —
VRAYLAR
  • AbbVie, Inc. $102
$102 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 26 with Patron

Records

327 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record